Haleon, a global consumer health company, is investing $54.2 million to upgrade its research & development (R&D) facility in Richmond, Virginia. The modernization will enable the company to expand ...

"Haleon's choice to expand its research capabilities and upgrade its Richmond facility strengthens the Commonwealth's pharmaceutical sector and highlights why Virginia is America’s Top State for ...

(Reuters) - Consumer healthcare company Haleon said on Wednesday it will invest $54 million in its global research and development centre in Richmond, U.S., aiming to boost its pipeline for new ...

“Haleon’s choice to expand its research capabilities and upgrade its Richmond facility strengthens the Commonwealth’s pharmaceutical sector and highlights why Virginia is America’s Top ...

In a room overlooking the River Thames, Virginia officials asked Haleon to choose Richmond for its investment. Where Haleon chooses to redevelop its facilities is limited, leaving localities to ...

Additionally, a five-year internship program will be launched in partnership with Virginia Commonwealth University (VCU) with help from equal investments provided by Haleon and the state.

Pharmaceutical company Haleon will invest $54.2 million to upgrade its research and development facility in Richmond and launch an internship program in partnership ...

(Reuters) - Consumer healthcare company Haleon said on Wednesday it will invest $54 million in its global research and development centre in Richmond, U.S., aiming to boost its pipeline for new ...